Accéder au contenu
Merck

Susceptibility testing of Dientamoeba fragilis ATCC 30948 with iodoquinol, paromomycin, tetracycline, and metronidazole.

Antimicrobial agents and chemotherapy (1994-05-01)
F T Chan, M X Guan, A M Mackenzie, F Diaz-Mitoma
RÉSUMÉ

Susceptibility testing was performed on Dientamoeba fragilis ATCC 30948 in a dixenic culture with Klebsiella pneumoniae and Bacteroides vulgatus. D. fragilis was cocultured with the bacteria in TYGM-9 medium (ATCC medium 1171). The activities of antiparasitic drugs were assessed by counting viable D. fragilis trophozoites with a hemacytometer by trypan blue exclusion. The minimal amebicidal concentrations of the following four drugs were determined: iodoquinol at 128 micrograms/ml, paromomycin at 16 micrograms/ml, tetracycline (questionably) at 32 micrograms/ml, and metronidazole at 32 micrograms/ml.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
5,7-Diiodo-8-hydroxyquinoline, 95%